News
A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...
The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
In July, the F.D.A. granted full approval to Moderna’s Covid vaccine for children — but only for those who have health conditions that may put them at increased risk should they become infected.
Washington, D.C. Mayor Muriel Bowser is holding a press conference following President Donald Trump's announcement Monday ...
Shares of Novavax Inc. NVAX shed 2.23% to $7.47 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.24% to 21,108. ...
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade July 24, 2025 — 05:45 pm EDT Written by Zacks Equity Research for Zacks -> ...
Peer-reviewed data shows Novavax's H5N1 vaccine candidate demonstrated immunogenicity against currently circulating variants following either single or two-dose administration Potential for single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results